LobbyingAdelanto Healthcare Ventures lobbying by quarter
Adelanto Healthcare Ventures's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q2 2025; the issues it reports most are Health Issues and Medicare/Medicaid.
Adelanto Healthcare Ventures
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2025 | $70K | 2 |
| Q3 2025 | $60K | 2 |
| Q4 2025 | $60K | 2 |
| Q1 2026 | $60K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$210K · 4 reports
- Medicare and Medicaid$70K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE6 reports
- HOUSE OF REPRESENTATIVES4 reports
- White House Office4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Foley & Lardner | $210K | 5 quarters |
| K&L Gates | $70K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOHN STROM | Senior Counsel - U.S. House Cmte on Energy & Commerce; Counsel - U.S. Senate Cmte on Health, Education, Labor, and Pensions; Associate General Counsel - U.S. Dept of Health and Human Services; Senior Counsel - U.S. House Cmte on Natural Resources | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/19for Q2 | Foley & Lardner | $30K |
| 04/20for Q1 | Foley & Lardner | $60K |
| 01/19for Q4 2025 | K&L Gates | Under $5,000 |
| 01/19for Q4 2025 | Foley & Lardner | $60K |
| 25/10/20for Q3 2025 | K&L Gates | Under $5,000 |
| 25/10/18for Q3 2025 | Foley & Lardner | $60K |
| 25/07/18for Q2 2025 | Foley & Lardner | Under $5,000 |
| 25/07/18for Q2 2025 | K&L Gates | $70K |
| 25/06/26for Q2 2025 | K&L Gates | Under $5,000 |
| 25/06/26for Q2 2025 | K&L Gates | Under $5,000 |
| 25/05/08for Q2 2025 | Foley & Lardner | Under $5,000 |